McGregor IS et al. |
A comparison of delta 9-THC and anandamide induced c-fos expression in the rat forebrain. |
1998 |
Brain Res. |
pmid:9748483
|
Schneider U et al. |
Cannabinoid/anandamide system and schizophrenia: is there evidence for association? |
1998 |
Pharmacopsychiatry |
pmid:9754842
|
Stengel PW et al. |
Pulmonary actions of anandamide, an endogenous cannabinoid receptor agonist, in guinea pigs. |
1998 |
Eur. J. Pharmacol. |
pmid:9754939
|
Pestonjamasp VK and Burstein SH |
Anandamide synthesis is induced by arachidonate mobilizing agonists in cells of the immune system. |
1998 |
Biochim. Biophys. Acta |
pmid:9795237
|
White R and Hiley CR |
The actions of some cannabinoid receptor ligands in the rat isolated mesenteric artery. |
1998 |
Br. J. Pharmacol. |
pmid:9806337
|
Patel NA et al. |
Arachidonylethanolamide (AEA) activation of FOS proto-oncogene protein immunoreactivity in the rat brain. |
1998 |
Brain Res. |
pmid:9666136
|
Calignano A et al. |
Control of pain initiation by endogenous cannabinoids. |
1998 |
Nature |
pmid:9685157
|
Stefano GB et al. |
Macrophage behavior associated with acute and chronic exposure to HIV GP120, morphine and anandamide: endothelial implications. |
1998 |
Int. J. Cardiol. |
pmid:9687087
|
Stefano GB |
Autoimmunovascular regulation: morphine and anandamide and ancondamide stimulated nitric oxide release. |
1998 |
J. Neuroimmunol. |
pmid:9610675
|
Stefano GB et al. |
Long-term exposure of human blood vessels to HIV gp120, morphine, and anandamide increases endothelial adhesion of monocytes: uncoupling of nitric oxide release. |
1998 |
J. Cardiovasc. Pharmacol. |
pmid:9641470
|
Mechoulam R et al. |
Endocannabinoids. |
1998 |
Eur. J. Pharmacol. |
pmid:9831287
|
Navarro M and RodrÃguez de Fonseca F |
The neurobiology of cannabinoid transmission: from anandamide signaling to higher cerebral functions and disease. |
1998 |
Neurobiol. Dis. |
pmid:9974172
|
Di Marzo V and Deutsch DG |
Biochemistry of the endogenous ligands of cannabinoid receptors. |
1998 |
Neurobiol. Dis. |
pmid:9974173
|
Piomelli D et al. |
Endogenous cannabinoid signaling. |
1998 |
Neurobiol. Dis. |
pmid:9974178
|
Barnett-Norris J et al. |
Exploration of biologically relevant conformations of anandamide, 2-arachidonylglycerol, and their analogues using conformational memories. |
1998 |
J. Med. Chem. |
pmid:9822555
|
Maccarrone M et al. |
Anandamide hydrolysis by human cells in culture and brain. |
1998 |
J. Biol. Chem. |
pmid:9822713
|
Axelrod J and Felder CC |
Cannabinoid receptors and their endogenous agonist, anandamide. |
1998 |
Neurochem. Res. |
pmid:9566594
|
Randall MD and Kendall DA |
Endocannabinoids: a new class of vasoactive substances. |
1998 |
Trends Pharmacol. Sci. |
pmid:9550942
|
Van der Kloot W et al. |
Calcitonin gene-related peptide acts presynaptically to increase quantal size and output at frog neuromuscular junctions. |
1998 |
J. Physiol. (Lond.) |
pmid:9508830
|
Di Marzo V et al. |
The novel endogenous cannabinoid 2-arachidonoylglycerol is inactivated by neuronal- and basophil-like cells: connections with anandamide. |
1998 |
Biochem. J. |
pmid:9512456
|
Adams IB et al. |
Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain. |
1998 |
J. Pharmacol. Exp. Ther. |
pmid:9495885
|
Edgemond WS et al. |
Human platelets and polymorphonuclear leukocytes synthesize oxygenated derivatives of arachidonylethanolamide (anandamide): their affinities for cannabinoid receptors and pathways of inactivation. |
1998 |
Mol. Pharmacol. |
pmid:9658204
|
Giuffrida A and Piomelli D |
Isotope dilution GC/MS determination of anandamide and other fatty acylethanolamides in rat blood plasma. |
1998 |
FEBS Lett. |
pmid:9498819
|
Tong W et al. |
Derivation of a pharmacophore model for anandamide using constrained conformational searching and comparative molecular field analysis. |
1998 |
J. Med. Chem. |
pmid:9784095
|
Richardson JD et al. |
Antihyperalgesic effects of spinal cannabinoids. |
1998 |
Eur. J. Pharmacol. |
pmid:9600630
|
Goparaju SK et al. |
Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand. |
1998 |
FEBS Lett. |
pmid:9475172
|
Hampson AJ et al. |
Dual effects of anandamide on NMDA receptor-mediated responses and neurotransmission. |
1998 |
J. Neurochem. |
pmid:9453561
|
Sulcova E et al. |
Biphasic effects of anandamide. |
1998 |
Pharmacol. Biochem. Behav. |
pmid:9476980
|
Kimura T et al. |
Anandamide, an endogenous cannabinoid receptor ligand, also interacts with 5-hydroxytryptamine (5-HT) receptor. |
1998 |
Biol. Pharm. Bull. |
pmid:9556149
|
Pratt PF et al. |
N-arachidonylethanolamide relaxation of bovine coronary artery is not mediated by CB1 cannabinoid receptor. |
1998 |
Am. J. Physiol. |
pmid:9458889
|
Paria BC et al. |
Effects of cannabinoids on preimplantation mouse embryo development and implantation are mediated by brain-type cannabinoid receptors. |
1998 |
Biol. Reprod. |
pmid:9623610
|
Mikawa Y et al. |
Ocular activity of topically administered anandamide in the rabbit. |
1997 Jul-Aug |
Jpn. J. Ophthalmol. |
pmid:9304433
|
Thomas EA et al. |
Fatty acid amide hydrolase, the degradative enzyme for anandamide and oleamide, has selective distribution in neurons within the rat central nervous system. |
1997 |
J. Neurosci. Res. |
pmid:9452020
|
Hunter SA and Burstein SH |
Receptor mediation in cannabinoid stimulated arachidonic acid mobilization and anandamide synthesis. |
1997 |
Life Sci. |
pmid:9126878
|
Bisogno T et al. |
The sleep inducing factor oleamide is produced by mouse neuroblastoma cells. |
1997 |
Biochem. Biophys. Res. Commun. |
pmid:9344854
|
Mechoulam R et al. |
Anandamide may mediate sleep induction. |
1997 |
Nature |
pmid:9288961
|
Hansen HS et al. |
Characterization of glutamate-induced formation of N-acylphosphatidylethanolamine and N-acylethanolamine in cultured neocortical neurons. |
1997 |
J. Neurochem. |
pmid:9231736
|
Castellano C et al. |
The effects of anandamide on memory consolidation in mice involve both D1 and D2 dopamine receptors. |
1997 |
Behav Pharmacol |
pmid:9832956
|
Wiley JL et al. |
Evaluation of cannabimimetic discriminative stimulus effects of anandamide and methylated fluoroanandamide in rhesus monkeys. |
1997 |
Pharmacol. Biochem. Behav. |
pmid:9408225
|
Randall MD et al. |
Comparative pharmacology of endothelium-derived hyperpolarizing factor and anandamide in rat isolated mesentery. |
1997 |
Eur. J. Pharmacol. |
pmid:9314035
|
Di Tomaso E et al. |
Endogenous lipids that activate cannabinoid receptors. Formation and inactivation. |
1997 |
Adv. Exp. Med. Biol. |
pmid:9321973
|
White R and Hiley CR |
A comparison of EDHF-mediated and anandamide-induced relaxations in the rat isolated mesenteric artery. |
1997 |
Br. J. Pharmacol. |
pmid:9422801
|
Zygmunt PM et al. |
Studies on the effects of anandamide in rat hepatic artery. |
1997 |
Br. J. Pharmacol. |
pmid:9422814
|
Jarrahian A and Hillard CJ |
Arachidonylethanolamide (anandamide) binds with low affinity to dihydropyridine binding sites in brain membranes. |
1997 |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:9431821
|
Sasaki T and Chang MC |
N-arachidonylethanolamine (anandamide) formation from N-arachidonylphosphatidylethanolamine in rat brain membranes. |
1997 |
Life Sci. |
pmid:9365227
|
Randall MD and Kendall DA |
Involvement of a cannabinoid in endothelium-derived hyperpolarizing factor-mediated coronary vasorelaxation. |
1997 |
Eur. J. Pharmacol. |
pmid:9369375
|
Burkey TH et al. |
Relative efficacies of cannabinoid CB1 receptor agonists in the mouse brain. |
1997 |
Eur. J. Pharmacol. |
pmid:9384246
|
Calignano A et al. |
Potentiation of anandamide hypotension by the transport inhibitor, AM404. |
1997 |
Eur. J. Pharmacol. |
pmid:9389389
|
Bloom AS et al. |
Nonclassical and endogenous cannabinoids: effects on the ordering of brain membranes. |
1997 |
Neurochem. Res. |
pmid:9131634
|
Deutsch DG and Makriyannis A |
Inhibitors of anandamide breakdown. |
1997 |
NIDA Res. Monogr. |
pmid:9260184
|
Yu M et al. |
Synthesis of prostaglandin E2 ethanolamide from anandamide by cyclooxygenase-2. |
1997 |
J. Biol. Chem. |
pmid:9261124
|
Welch SP |
Characterization of anandamide-induced tolerance: comparison to delta 9-THC-induced interactions with dynorphinergic systems. |
1997 |
Drug Alcohol Depend |
pmid:9179505
|
van der Stelt M et al. |
Dioxygenation of N-linoleoyl amides by soybean lipoxygenase-1. |
1997 |
FEBS Lett. |
pmid:9271222
|
Stefano GB et al. |
Morphine- and anandamide-stimulated nitric oxide production inhibits presynaptic dopamine release. |
1997 |
Brain Res. |
pmid:9272829
|
Schmid PC et al. |
Anandamide and other N-acylethanolamines in mouse peritoneal macrophages. |
1997 |
Chem. Phys. Lipids |
pmid:9275307
|
Seltzman HH et al. |
Synthesis and pharmacological comparison of dimethylheptyl and pentyl analogs of anandamide. |
1997 |
J. Med. Chem. |
pmid:9357529
|
Cadogan AK et al. |
Influence of cannabinoids on electrically evoked dopamine release and cyclic AMP generation in the rat striatum. |
1997 |
J. Neurochem. |
pmid:9282935
|
Deutsch DG et al. |
Production and physiological actions of anandamide in the vasculature of the rat kidney. |
1997 |
J. Clin. Invest. |
pmid:9294122
|
Kurahashi Y et al. |
Reversible hydrolysis and synthesis of anandamide demonstrated by recombinant rat fatty-acid amide hydrolase. |
1997 |
Biochem. Biophys. Res. Commun. |
pmid:9299394
|
Wenger T et al. |
Arachidonyl ethanolamide (anandamide) activates the parvocellular part of hypothalamic paraventricular nucleus. |
1997 |
Biochem. Biophys. Res. Commun. |
pmid:9299434
|
Wenger T et al. |
The effects of prenatally administered endogenous cannabinoid on rat offspring. |
1997 |
Pharmacol. Biochem. Behav. |
pmid:9300616
|
Hillard CJ et al. |
Accumulation of N-arachidonoylethanolamine (anandamide) into cerebellar granule cells occurs via facilitated diffusion. |
1997 |
J. Neurochem. |
pmid:9231721
|
Wenger T et al. |
Effects of anandamide on gestation in pregnant rats. |
1997 |
Life Sci. |
pmid:9199480
|
Molina-Holgado F et al. |
Anandamide suppresses nitric oxide and TNF-alpha responses to Theiler's virus or endotoxin in astrocytes. |
1997 |
Neuroreport |
pmid:9223079
|
Willoughby KA et al. |
The biodisposition and metabolism of anandamide in mice. |
1997 |
J. Pharmacol. Exp. Ther. |
pmid:9223560
|
Beltramo M et al. |
Inhibition of anandamide hydrolysis in rat brain tissue by (E)-6-(bromomethylene) tetrahydro-3-(1-naphthalenyl)-2H-pyran-2-one. |
1997 |
FEBS Lett. |
pmid:9091314
|
Thumser AE et al. |
A fluorescence displacement assay for the measurement of arachidonoyl ethanolamide (anandamide) and oleoyl amide (octadecenoamide) hydrolysis. |
1997 |
Biochem. Pharmacol. |
pmid:9065749
|
Ryan WJ et al. |
Potent anandamide analogs: the effect of changing the length and branching of the end pentyl chain. |
1997 |
J. Med. Chem. |
pmid:9357528
|
Bisogno T et al. |
Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoylglycerol in mouse neuroblastoma cells. |
1997 |
Biochem. J. |
pmid:9065792
|
De Petrocellis L et al. |
Novel inhibitors of brain, neuronal, and basophilic anandamide amidohydrolase. |
1997 |
Biochem. Biophys. Res. Commun. |
pmid:9070224
|
Deutsch DG et al. |
Fatty acid sulfonyl fluorides inhibit anandamide metabolism and bind to the cannabinoid receptor. |
1997 |
Biochem. Biophys. Res. Commun. |
pmid:9070252
|
Lake KD et al. |
Cardiovascular effects of anandamide in anesthetized and conscious normotensive and hypertensive rats. |
1997 |
Hypertension |
pmid:9149688
|
Bisogno T et al. |
Occurrence and metabolism of anandamide and related acyl-ethanolamides in ovaries of the sea urchin Paracentrotus lividus. |
1997 |
Biochim. Biophys. Acta |
pmid:9150253
|
Stefano GB et al. |
Identification and characterization of the leech CNS cannabinoid receptor: coupling to nitric oxide release. |
1997 |
Brain Res. |
pmid:9125406
|
Mechoulam R |
Todd's achievement. |
1997 |
Nature |
pmid:9126725
|
Koga D et al. |
Liquid chromatographic-atmospheric pressure chemical ionization mass spectrometric determination of anandamide and its analogs in rat brain and peripheral tissues. |
1997 |
J. Chromatogr. B Biomed. Sci. Appl. |
pmid:9106024
|
Schmid PC et al. |
Changes in anandamide levels in mouse uterus are associated with uterine receptivity for embryo implantation. |
1997 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:9108127
|
Cadas H et al. |
Occurrence and biosynthesis of endogenous cannabinoid precursor, N-arachidonoyl phosphatidylethanolamine, in rat brain. |
1997 |
J. Neurosci. |
pmid:9006968
|
Sheskin T et al. |
Structural requirements for binding of anandamide-type compounds to the brain cannabinoid receptor. |
1997 |
J. Med. Chem. |
pmid:9057852
|
Bisogno T et al. |
Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes. |
1997 |
J. Biol. Chem. |
pmid:9013571
|
Fowler CJ et al. |
Ibuprofen inhibits the metabolism of the endogenous cannabimimetic agent anandamide. |
1997 |
Pharmacol. Toxicol. |
pmid:9060042
|
Salzet M et al. |
Leech immunocytes contain proopiomelanocortin: nitric oxide mediates hemolymph proopiomelanocortin processing. |
1997 |
J. Immunol. |
pmid:9548480
|
Calignano A et al. |
Inhibition of intestinal motility by anandamide, an endogenous cannabinoid. |
1997 |
Eur. J. Pharmacol. |
pmid:9537804
|
Pate DW et al. |
Effects of topical alpha-substituted anandamides on intraocular pressure in normotensive rabbits. |
1997 |
Pharm. Res. |
pmid:9453062
|
Hillard CJ and Campbell WB |
Biochemistry and pharmacology of arachidonylethanolamide, a putative endogenous cannabinoid. |
1997 |
J. Lipid Res. |
pmid:9458263
|
Berdyshev EV et al. |
Influence of fatty acid ethanolamides and delta9-tetrahydrocannabinol on cytokine and arachidonate release by mononuclear cells. |
1997 |
Eur. J. Pharmacol. |
pmid:9253958
|
Plane F et al. |
Evidence that anandamide and EDHF act via different mechanisms in rat isolated mesenteric arteries. |
1997 |
Br. J. Pharmacol. |
pmid:9283682
|
Fowler CJ et al. |
Ibuprofen inhibits rat brain deamidation of anandamide at pharmacologically relevant concentrations. Mode of inhibition and structure-activity relationship. |
1997 |
J. Pharmacol. Exp. Ther. |
pmid:9353392
|
Stark S et al. |
Binding of aminoalkylindoles to noncannabinoid binding sites in NG108-15 cells. |
1997 |
Cell. Mol. Neurobiol. |
pmid:9353590
|
van der Stelt M et al. |
The effect of hydroxylation of linoleoyl amides on their cannabinomimetic properties. |
1997 |
FEBS Lett. |
pmid:9357990
|
Beltramo M et al. |
Functional role of high-affinity anandamide transport, as revealed by selective inhibition. |
1997 |
Science |
pmid:9262477
|
Valk P et al. |
Anandamide, a natural ligand for the peripheral cannabinoid receptor is a novel synergistic growth factor for hematopoietic cells. |
1997 |
Blood |
pmid:9269762
|
Brodkin J and Moerschbaecher JM |
SR141716A antagonizes the disruptive effects of cannabinoid ligands on learning in rats. |
1997 |
J. Pharmacol. Exp. Ther. |
pmid:9316868
|
Twitchell W et al. |
Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons. |
1997 |
J. Neurophysiol. |
pmid:9242259
|
Matsuda S et al. |
Metabolism of anandamide, an endogenous cannabinoid receptor ligand, in porcine ocular tissues. |
1997 |
Exp. Eye Res. |
pmid:9245900
|
Fernández-Ruiz JJ et al. |
Time course of the effects of different cannabimimetics on prolactin and gonadotrophin secretion: evidence for the presence of CB1 receptors in hypothalamic structures and their involvement in the effects of cannabimimetics. |
1997 |
Biochem. Pharmacol. |
pmid:9256167
|
Wagner JA et al. |
Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock. |
1997 |
Nature |
pmid:9394002
|
Burkey RT and Nation JR |
(R)-methanandamide, but not anandamide, substitutes for delta 9-THC in a drug-discrimination procedure. |
1997 |
Exp Clin Psychopharmacol |
pmid:9260067
|
Compton DR and Martin BR |
The effect of the enzyme inhibitor phenylmethylsulfonyl fluoride on the pharmacological effect of anandamide in the mouse model of cannabimimetic activity. |
1997 |
J. Pharmacol. Exp. Ther. |
pmid:9399986
|
Stella N et al. |
A second endogenous cannabinoid that modulates long-term potentiation. |
1997 |
Nature |
pmid:9285589
|